(Press-News.org) WASHINGTON -- Liver transplant is a lifesaving surgery, but a significant number of patients experience organ rejection or other complications. Now a new study by scientists from Georgetown University and MedStar Health describes how a single blood sample can be used to catch problems at the earliest stages, allowing tailored treatment to prevent the organ’s failure.
The research, funded in part by the National Institutes of Health, is a major step toward the development of a liquid biopsy that could not only quickly detect post-transplant complications but also pinpoint the cause. The technology would largely eliminate the need for more invasive tests.
The findings were published June 17 in the journal Nature Communications (“Circulating, cell-free methylated DNA indicates cellular sources of allograft injury after liver transplant” DOI: 10.1038/s41467-025-60507-9).
“There’s a need for a much better and more granular understanding of what’s driving a transplant failure,” said Anton Wellstein, MD, PhD, professor of oncology and pharmacology at Georgetown’s Lombardi Comprehensive Cancer Center, and senior author of the study. “With this technology we can draw a blood sample and pretty much get a readout of what’s going on with the whole patient.”
Liver transplants are only given to patients who are in desperate need; unlike other organs like the kidneys, which can be supported with dialysis, there are no machines or treatments that can save a patient when the liver fails. And because there is just a limited supply of livers available for transplant, preventing organ injury is of paramount importance, said study co-author, Alexander Kroemer, MD, PhD, a transplant surgeon at MedStar Georgetown University Hospital and director of the Center for Translational Transplant Medicine at Georgetown University Medical Center.
There are several ways a transplanted organ can sustain damage. The transplantation process itself can injure the new liver, place stress on nearby organs and trigger an immune response.
Currently, transplant doctors can use blood tests to detect potential damage and genetic testing to determine whether the damaged cells originate from the donated liver or the patient’s own body. However, identifying the precise cause often requires costly imaging studies or invasive follow-up tests, such as a liver biopsy.
The new technology works by picking up DNA fragments found in the debris left behind by dying cells circulating in the bloodstream. Wellstein’s team found that chemical signatures left behind on these DNA fragments could be used to identify the original cell type and where it came from, with precise detail.
“What’s new is that we can now figure out the cellular origin of the damage,” Wellstein explained. “We can pinpoint the cell types, either in the transplanted organ or in the host, in other tissues that are getting damaged or under threat of damage.”
The convenience of the test means it can be repeated at frequent intervals, he noted, making it easier for doctors to monitor patients and detect problems early.
“If you were to know, for instance, that the biliary compartment [of the liver] is injured but not the hepatocellular compartment, you could provide a more personalized treatment approach that leads to better care for the patient,” Kroemer said.
In addition to being faster and less invasive than a traditional tissue biopsy, the blood test is also potentially more accurate, he added. “With needle biopsies, there’s always the potential for sampling bias, because you’re not sampling the whole liver,” he said. “It’s just one small core that’s being evaluated.”
When researchers started the project seven years ago they had no idea if it would even be possible to detect cell damage in blood samples.
“It was amazing how well it worked,” Wellstein said.
The research was supported by a $2.5 million grant from the NIH. It originally started as a research project by first author Megan McNamara, an MD/PhD student at Georgetown. McNamara was supported by an NIH-funded training grant for PhD students.
Georgetown has filed patent applications on the technology with Wellstein, Kroemer and McNamara named as co-inventors. The researchers are studying additional applications, including in other organ transplants, in patients receiving radiation therapy for breast cancer, and in melanoma treatment.
The team is also seeking partners to commercialize the technology for clinical settings.
“We can make the discovery -- that’s where academia comes in -- but if you want to translate it for use in transplantation, it has to go to industry,” he said.
###
In addition to Wellstein, Kroemer and McNamara, other authors include Sidharth S. Jain, Amber J. Kiliti, Marcel O. Schmidt, A. Patrick McDeed, and Anna T. Riegel at Georgetown; Kesha Oza, Vinona Muralidaran, Digvijay Patil, and Yuki Cui at Medstar Health. The additional authors report having no personal financial interests related to the study.
This work was supported by funding from the National Institutes of Health grant T32-CA009686, F30-CA250307, R01-AI132389, R01-CA231291, and P30-CA51008.
END
Bladder tumors that have been excluded from clinical trials have a few things in common that could lead to new therapies.
Scientists at UC San Francisco have found a way to identify and possibly treat a mysterious type of bladder cancer that affects up to 1 in 4 cases.
First, they found a marker on the surface of the tumor cells that until now had only been associated with ovarian cancer; then they designed CAR-T therapy to kill the tumors in mice.
The discovery, which was made possible through funding from the National Institutes of Health (NIH), appears ...
In a world-first breakthrough, researchers have used an epilepsy-like disease model in a laboratory dish and showed that improved information processing and neural function can be achieved using a medication designed specifically to treat the disease. Published in Communications Biology, the research was led by Cortical Labs and marks a significant breakthrough in the study and treatment of neurological disorders in real time.
Cortical Labs is an Australian start-up which created the world’s first commercial biological computer, the CL1, which fuses lab-cultivated neurons from human stem cells with hard silicon to create ...
Wildfires pollute waterways and could affect their ability to sequester carbon, recent University of British Columbia research shows.
Dr. Brian Hunt, professor in the Institute for the Oceans and Fisheries (IOF), and Emily Brown, IOF research scientist, discuss how wildfires affect our waters and what this means in a changing climate.
What did you find about how fire affects water?
BH: We focused on the mighty Fraser River basin. When forests burn, they release ash, soil particles and chemicals into the environment. In a recent study which analyzed water quality and wildfire data, we were able to link increases in the concentrations of compounds like arsenic and lead, as well as nutrients ...
It might be hard to imagine, but dropping a limb or two is routine for spiders. If moulting goes wrong or a leg gets stuck, the pragmatic arachnids simply detach the limb just beyond the body joint. Then it regrows within a month when they are young. But how do impaired spiders cope when suddenly relieved of a couple of limbs? Capturing dinner and evading predators could become an issue. However, going down from eight to six legs might not be a problem if spiders are adaptable. Maybe they relearn how to manoeuvre on just ...
For the first time, a research team led by Markus Koch from the Institute of Experimental Physics at Graz University of Technology (TU Graz) has tracked in real time how individual atoms combine to form a cluster and which processes are involved. To achieve this, the researchers first isolated magnesium atoms using superfluid helium and then used a laser pulse to trigger the formation process. The researchers were able to observe this cluster formation and the involved energy transfer between individual atoms with a temporal ...
Six out of ten people with type 2 diabetes had fatty liver in a new study from Linköping University. Of these, only a small percentage had developed more severe liver disease. The study, published in the Journal of Internal Medicine, also helps confirm that those who have type 2 diabetes in combination with obesity are at greater risk of fatty liver leading to more severe liver disease.
When metabolism does not work normally, as with so-called metabolic syndrome, many organs in the body are affected.
“Metabolic syndrome is a combination of factors leading to the body accumulating fat and not managing blood sugar levels in a good way. This entails an increased risk of developing ...
A new study from the Stockholm School of Economics finds that the competitiveness of green steel production in Romania partly hinges on hydrogen sourcing—requiring a 15 percent price premium if hydrogen is purchased externally as supposed to produced on-site. Without this premium, decarbonizing the country’s only primary steel producer could result in billions of losses.
The research, published in the Journal of Industrial Ecology, evaluates the financial viability of Liberty Steel Galați’s transition to low-carbon steelmaking using green hydrogen and electric arc furnace-based technologies. The plant, one of the EU’s top 10 most polluting steel facilities, aims ...
According to the first-ever survey fielded to RAND’s new American Youth Panel (AYP), 49% of students in middle and high school grades reported losing interest in math about half or more of the time, and 75% of youths reported losing interest for at least some class time.
Loss of interest in math is consistent across genders and racial and ethnic groups.
In the fall of 2024, RAND asked youths in grades 5 through 12 about their math class experiences with plans to measure these math attitudes annually to track trends over time. This nationally representative report was fielded to a group of ...
The Hebrew University of Jerusalem proudly congratulates three of its esteemed researchers – Prof. Dorit Aharonov, Prof. Israel Nelken, and Prof. Tamar Ziegler – on being awarded the highly competitive European Research Council (ERC) Advanced Grants.
This prestigious recognition, part of the EU’s Horizon Europe programme, supports senior researchers in pursuing ambitious, curiosity-driven projects with the potential to make significant scientific breakthroughs. The ERC Advanced Grant competition is one of ...
Amid concerns over rising petroleum prices and resource depletion, organic compounds such as methanol are attracting attention as potential replacements. Though this bodes well in theory, the production of raw materials from methanol relies on costly chemical processes. An energy-saving, bio-based process is necessary for fully tapping into this resource.
To make this a reality, Associate Professor Ryosuke Yamada’s team at Osaka Metropolitan University’s Graduate School of Engineering has developed a Komagataella phaffii (K. phaffii) yeast strain that can efficiently produce D-lactic acid, a raw material for ...
